Healthcare -
Biotechnology - NASDAQ - CH
$ 43.81
5.64 %
$ 2.76 B
Market Cap
-34.5
P/E
MLTX - COST OF REVENUE
Cost of Revenue MLTX - MoonLake Immunotherapeutics
13.2 K
LAST VALUE
62.69%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR